HealthHansoh-GSK bone cancer drug slows disease progression in late-stage China study
Data presented by researchers at a medical meeting on Monday showed that an experimental drug for a hard-to-treat bone cancer, developed by Hansoh Pharmaceutical and GSK, helped patients live longer without their disease worsening.
R
Reuters★★☆☆☆2026-10-26 19:25Original
Hansoh-GSK bone cancer drug slows disease progression in late-stage China study
Health